SAFETY AND EFFICACY

Clinical trials for SAFETY AND EFFICACY explained in plain language.

Never miss a new study

Get alerted when new SAFETY AND EFFICACY trials appear

Sign up with your email to follow new studies for SAFETY AND EFFICACY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1

Engineered immune cells show promise against tough blood cancer

Disease control Ongoing

This study tests a treatment that uses a patient's own immune cells, modified to target two proteins (CD19 and BCMA) on myeloma cells, after a stem cell transplant. The goal is to see if this approach is safe and can control high-risk multiple myeloma. About 43 participants will …

Matched conditions: SAFETY AND EFFICACY

Phase: PHASE1, PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control

Last updated May 15, 2026 11:55 UTC

SAFETY AND EFFICACY

Get alerted when new SAFETY AND EFFICACY trials appear

Engineered immune cells show promise against tough blood cancer